HALOZYME THERAPEUTICS, INC. (HALO) /
The revenue of HALOZYME THERAPEUTICS, INC. over the past 10 years
Chart HALOZYME THERAPEUTICS, INC.: revenue, fiscal 2016–2025 Open the chart →HALOZYME THERAPEUTICS, INC. reported revenue of $1.4B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $146.69M — up 852% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2017: up 116%, from $146.69M to $316.61M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $1.4B |
| 2024ended Dec 31, 2024 | $1.02B |
| 2023ended Dec 31, 2023 | $829.25M |
| 2022ended Dec 31, 2022 | $660.12M |
| 2021ended Dec 31, 2021 | $443.31M |
| 2020ended Dec 31, 2020 | $267.59M |
| 2019ended Dec 31, 2019 | $195.99M |
| 2018ended Dec 31, 2018 | $151.86M |
| 2017ended Dec 31, 2017 | $316.61M |
| 2016ended Dec 31, 2016 | $146.69M |
Fiscal years as HALOZYME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on HALOZYME THERAPEUTICS, INC.
- The profitability of HALOZYME THERAPEUTICS, INC.
- The cash flow of HALOZYME THERAPEUTICS, INC.
- The debt of HALOZYME THERAPEUTICS, INC.
- All of HALOZYME THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- ALLEAllegion plc
- PNFPPINNACLE FINANCIAL PARTNERS, INC.
- JHXJAMES HARDIE INDUSTRIES plc
- SUISUN COMMUNITIES, INC
- BZKANZHUN LIMITED
Not investment advice. This page shows what HALOZYME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.